NO743667L - - Google Patents

Info

Publication number
NO743667L
NO743667L NO743667A NO743667A NO743667L NO 743667 L NO743667 L NO 743667L NO 743667 A NO743667 A NO 743667A NO 743667 A NO743667 A NO 743667A NO 743667 L NO743667 L NO 743667L
Authority
NO
Norway
Prior art keywords
group
methyl
cephem
hydrogen
compound
Prior art date
Application number
NO743667A
Other languages
English (en)
Norwegian (no)
Inventor
W E Barth
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO743667L publication Critical patent/NO743667L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO743667A 1973-10-17 1974-10-11 NO743667L (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US40709773A 1973-10-17 1973-10-17

Publications (1)

Publication Number Publication Date
NO743667L true NO743667L (da) 1975-05-12

Family

ID=23610572

Family Applications (1)

Application Number Title Priority Date Filing Date
NO743667A NO743667L (da) 1973-10-17 1974-10-11

Country Status (22)

Country Link
JP (3) JPS50121293A (da)
AR (2) AR209283A1 (da)
BE (1) BE821164A (da)
CA (1) CA1064019A (da)
DD (1) DD114266A5 (da)
DE (1) DE2449834A1 (da)
DK (1) DK542174A (da)
ES (4) ES431069A1 (da)
FR (1) FR2257298B1 (da)
GB (4) GB1481808A (da)
IE (1) IE40745B1 (da)
IL (1) IL45849A0 (da)
LU (1) LU71128A1 (da)
MW (2) MW4174A1 (da)
NL (1) NL7413643A (da)
NO (1) NO743667L (da)
OA (1) OA04935A (da)
PL (1) PL95747B1 (da)
SE (2) SE429342B (da)
SU (1) SU974936A3 (da)
ZA (1) ZA746544B (da)
ZM (1) ZM16174A1 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6006201B2 (ja) * 2011-04-28 2016-10-12 塩野義製薬株式会社 カテコールまたは擬似カテコール構造を有する新規セフェム化合物
WO2013002215A1 (ja) * 2011-06-27 2013-01-03 塩野義製薬株式会社 ピリジニウム基を有するセフェム化合物

Also Published As

Publication number Publication date
JPS50121293A (da) 1975-09-23
FR2257298B1 (da) 1978-06-30
MW4074A1 (en) 1976-01-14
ZM16174A1 (en) 1975-06-23
ES431069A1 (es) 1977-02-01
SE7412602L (da) 1975-04-18
ES450399A1 (es) 1977-08-16
SE7710697L (sv) 1977-09-23
AR213726A1 (es) 1979-03-15
BE821164A (fr) 1975-04-17
ES450398A1 (es) 1977-09-01
GB1481810A (en) 1977-08-03
PL95747B1 (pl) 1977-11-30
DE2449834A1 (de) 1975-04-30
ZA746544B (en) 1975-10-29
DD114266A5 (da) 1975-07-20
IE40745L (en) 1975-04-17
IE40745B1 (en) 1979-08-15
JPS57145882A (en) 1982-09-09
AR209283A1 (es) 1977-04-15
GB1481808A (en) 1977-08-03
DK542174A (da) 1975-06-16
NL7413643A (nl) 1975-04-21
CA1064019A (en) 1979-10-09
FR2257298A1 (da) 1975-08-08
ES450397A1 (es) 1977-08-16
GB1481809A (en) 1977-08-03
SU974936A3 (ru) 1982-11-15
AU7442574A (en) 1976-04-29
LU71128A1 (da) 1975-06-24
OA04935A (fr) 1980-10-31
MW4174A1 (en) 1976-06-09
SE429342B (sv) 1983-08-29
JPS58131988A (ja) 1983-08-06
JPS5822480B2 (ja) 1983-05-09
IL45849A0 (en) 1974-12-31
GB1481807A (en) 1977-08-03

Similar Documents

Publication Publication Date Title
CA1059988A (en) Process for the manufacture of enol derivatives
NO782866L (no) Fremgangsmaate for fremstilling av cefalosporinderivater
JPH05509089A (ja) セファロスポリンおよび同族体、製法および医薬組成物
US4147864A (en) Process for the manufacture of 7β-amino-3-cephem-3-ol-4 carboxylic acid compounds
US3759904A (en) Ds and salts thereof 3 - (s-(1,2,3-triazole-5-yl)thiomethyl)-3 - cephem - 4-carboxylic aci7-(d-(alpha-amino-alpha-phenyl-, 2-thienyl- and 3-thienylacetamido))-
US4254119A (en) 3-Unsubstituted-3-cephem compounds
US4285941A (en) Cephalosporin compounds and antibacterial drugs containing the same
SU867311A3 (ru) Способ получени D-7-[ @ -(4-окси-6-метилникотинамидо)- @ -(4-оксифенил)ацетамидо-3-(1-МЕТИЛТЕТРАЗОЛ-5-ИЛТИОМЕТИЛ)-3-ЦЕФЕМ-4-КАРБОНОВОЙ КИСЛОТЫ
EP0796262B1 (en) 7-alkylidene cephalosporanic acid derivatives and methods of using the same
US3813388A (en) 7-(d-(alpha-amino-alpha-phenyl-,2-thienyl-and 3-thienyl-acetamido))-3-(s-(2-methyl-1,2,3-triazole-4-yl)thiomethyl)-3-cephem-4-carboxylic acids
US3966719A (en) 4-(Tetrazol-5-yl)-Δ3 -cephem compounds
JPH02121995A (ja) 新規化合物、その製法及びそれを含む医薬組成物
US4059578A (en) 7-Substituted mercaptoacetamido cephamycins
US4104469A (en) 7-(Syn-α-alkoxy-iminofuryl)acetamido-3-(2-methyl-2,3-dihydro-s-triazolo[4,3-b]pyridazin-3-on-6-ylthiomethyl)-3-cephem-4-carboxylic acids
NO743667L (da)
US3814755A (en) 7-(omikron-aminomethylphenylacetamido)-3-(tetrazolo(4,5-b)pyridazin-6-ylthiomethyl)-3-cephem-4-carboxylic acid
FI66619B (fi) Foerfarande foer framstaellning av farceutiskt anvaendbara 7beta-(d-2-amino-2-(laogalkylsulfonylaminofenyl)-asetylamino)-3-r-3-cefem-4-karboxylsyror
US4039532A (en) 4-(Tetrazol-5-yl)-Δ3 -cephem compounds
US4103085A (en) 7-(Syn-α-alkoxy-iminofurylacetamido-3-(2-carboxyalkyl-2,3-dihydro-s-triazolo[4,3-b]pyridazin-3-on-6-ylthiomethyl)-3-cephem-4-carboxylic acids
US4045436A (en) 4-(Tetrazol-5-yl)-Δ3 -cephem compounds
US4045437A (en) 4-(Tetrazol-5-yl)-Δ3 -cephem compounds
US4109083A (en) 4-(Tetrazol-5-yl)-Δ3 -cephem compounds
US4129732A (en) 4(Tetrazol-5-yl)-Δ3 -cephem compounds
US3780032A (en) 7-(d-(alpha-amino-alpha-phenyl-,2-thienyl-and 3-thienylacetamido)-3-(s-(1-methyl-1,2,3-triazol-4-yl)carbonyl)thiomethyl-3-cephem-4-carboxylic acids
US4113942A (en) 4-(Tetrazol-5-yl)-Δ3 -cephem compounds